Specific targeting of human epidermal growth factor receptor 2 (HER2) overexpressing breast cancer cells by polyethylene glycol-grafted polyethyleneimine modified with anti-HER2 single-domain antibody

Abstract

Polyethyleneimine is one of the most efficient non-viral gene delivery agents. However, some limitations such as non-specific cell binding, interactions with blood components, and relatively high cytotoxicity restrict its in vivo applications. In order to improve the properties of this molecule as a gene transfection vector, in this study, we developed a nano-carrier system based on polyethyleneimine derivatives synthesized by grafting bi-functional polyethylene glycol molecules (MAL-PEG₃₅₀₀-NHS) to 25 kDa branched polyethyleneimine polymer at three different molar ratios of 10, 20, and 30 (polyethylene glycol:polyethyleneimine). Variable domain of heavy-chain antibody against human epidermal growth factor receptor 2 as targeting agent was conjugated to polyethylene glycol–polyethyleneimine copolymer. In order to find the most effective resultant conjugate, the effect of these modifications on physicochemical properties, cytotoxicity, cellular uptake, and gene transfection efficiency of polyethyleneimine polymer was evaluated. According to the findings of this study and compared to unconjugated polyethyleneimine, PEGylated polyethyleneimine copolymers exhibit lower in vitro cytotoxicity. Polyethylene glycol–polyethyleneimine copolymer conjugated at a molar ratio of 10:1 (polyethylene glycol:polyethyleneimine) demonstrated a low cytotoxicity effect and desirable physicochemical properties. Anti-human epidermal growth factor receptor 2 variable domain of heavy-chain antibody conjugation further reduced the cytotoxicity of unmodified polyethyleneimine in all cell lines studied by 1.5- to 2-folds and also resulted in higher cellular uptake and transfection ability of this copolymer in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines versus normal breast cells or human epidermal growth factor receptor 2 negative cell lines. Altogether, our data suggested that variable domain of heavy-chain antibody–polyethylene glycol–polyethyleneimine copolymers might be an efficient nano-carrier system for specific targeting of human epidermal growth factor receptor 2 expressing tumors.

Keywords

Polyethyleneimine polyethylene glycol human epidermal growth factor receptor 2 variable domain of heavy-chain antibody cytotoxicity gene transfection

Get full access to this article

View all access options for this article.

References

Liu

Huang

Development of non-viral vectors for systemic gene delivery. J Control Release 2002; 78: 259–266.

Ogris

Wagner

Targeting tumors with non-viral gene delivery systems. Drug Discov Today 2002; 15: 479–485.

Guo

Gosselin

Lee

RJ.

Characterization of a novel diolein-based LPDII vector for gene delivery. J Control Release 2002; 83: 121–132.

Gosselin

Guo

Lee

RJ.

Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjug Chem 2001; 12: 989–994.

Guillem

Tormo

Revert

et al . Polyethyleneimine-based immunopolyplex for targeted gene transfer in human lymphoma cell lines. J Gene Med 2002; 4: 170–182.

Boussif

Lezoulac’h

Zanta

et al . A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A 1995; 92: 7297–7301.

Godbey

Mikos

AG.

Poly(ethylenimine) and its role in gene delivery. J Control Release 1999; 60: 149–160.

Sonawane

Szoka

Verkman

AS.

Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003; 278: 44826–44831.

Ogris

Brunner

Schueller

et al . PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595–605.

10.

Diebold

Kursa

Wagner

et al . Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells. J Biol Chem 1999; 274: 19087–19094.

11.

Erbacher

Remy

Behr

JP.

Gene transfer with synthetic virus-like particles via the integrinmediated endocytosis pathway. Gene Ther 1999; 6: 138–145.

12.

Kircheis

Kichler

Wallner

et al . Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther 1997; 4: 409–418.

13.

Wagner

Zenke

Cotten

et al . Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc Natl Acad Sci U S A 1990; 87: 3410–3414.

14.

Lee

Huang

Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481–8487.

15.

Buschle

Cotten

Kirlappos

et al . Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther 1995; 6: 753–761.

16.

Altintas

Kok

Schiffelers

RM.

Targeting epidermal growth factor receptor in tumors: from conventional monoclonal antibodies via heavy chain-only antibodies to nanobodies. Eur J Pharm Sci 2012; 45: 399–407.

17.

Hamers-Casterman

Atarhouch

Muyldermans

Naturally occurring antibodies devoid of light chains. Nature 1993; 363: 446–448.

18.

Rahbarizadeh

Ahmadvand

Sharifzadeh

Nanobody; an old concept and new vehicle for immunotargeting. Immunol Invest 2011; 40: 299–338.

19.

Harmsen

De Haard

HJ.

Properties, production and applications of camelid single-domain antibody fragments. Appl Microbial Biotechnol 2007; 77: 13–22.

20.

Gianni

Eiermann

Semiglazov

et al . Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet 2010; 375: 377–384.

21.

Jamnani

Rahbarizadeh

Shokrgozar

et al . Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells. Exp Cell Res 2012; 318: 1112–1124.

22.

Snyder

Sobocinski

PZ.

An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines. Anal Biochem 1975; 64: 284–288.

23.

Nikkhoi

Rahbarizadeh

Ahmadvand

Oligo-clonal nanobodies as an innovative targeting agent for cancer therapy: new biology and novel targeting systems. Protein Expr Purif 2017; 129: 115–121.

24.

Rahbarizadeh

Rasaee

Forouzandeh Moghadam

et al . Production of novel recombinant single-domain antibodies against tandem repeat region of MUC1 mucin. Hybrid Hybridomics 2004; 23: 151–159.

25.

Beatty

Vlahos

WG.

Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987; 100: 173–179.

26.

Merdan

Callahan

Petersen

et al . Pegylated polyethylenimine-Fab′ antibody fragment conjugates for targeted gene delivery to human ovarian carcinoma cells. Bioconjug Chem 2003; 14: 989–996.

27.

Massa

Xavier

Vos

et al . Site-specific labeling of cysteine-tagged camelid singled-domain antibody-fragments for use in molecular imaging. Bioconjug Chem 2014; 25: 979–988.

28.

Safarian

Rahbarizadeh

Amanpour

et al . Construction of PEG-PAMAM dendrimer-based TG72-targeting nanocarrier for t-Bid gene delivery to colorectal tumor cells. Modares J Med Sci 2011; 14: 63–74.

29.

Petersen

Fechner

Martin

et al . Polyethylenimine-graft-poly (ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem 2002; 13: 845–854.

30.

Remaut

Lucas

Raemdonck

et al . Protection of oligonucleotides against enzymatic degradation by pegylated and nonpegylated branched polyethyleneimine. Biomacromolecules 2007; 8: 1333–1340.

31.

Germershaus

Merdan

Bakowsky

et al . Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors. Bioconjug Chem 2006; 17: 1190–1199.

32.

Mellman

Endocytosis and molecular sorting. Annu Rev Cell Dev Biol 1995; 12: 575–625.

33.

Dong

Jin

et al . Efficient gene transfection into mammalian cells mediated by cross-linked polyethylenimine. Int J Mol Sci 2007; 8: 81–102.

34.

Huang

Wang

et al . PEGylated PEI-based biodegradable polymers as non-viral gene vectors. Acta Biomater 2010; 6(11): 4285–4295.

35.

Wen

Pan

Luo

et al . PDMAEG-graft-modified branched PEI as novel gene vector: synthesis, characterization and gene transfection. J Biomater Sci Polym Ed 2010; 21(8–9): 1103–1126.

36.

Steinhausera

Spänkuchb

Strebhardtb

et al . Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells. Biomaterials 2006; 27: 4975–4983.